Scramble to fend off takeover: Allergan vs. Valeant

Valeant Pharmaceuticals International; Market Cap. (as of 3/10/2014): $42.9bn Allergan Inc.; Market Cap. (as of 3/10/2014): $53.64bn As low debt obligations alongside large cash holdings and patent expiration liabilities continue to foster a conducive environment for M&A activity in the pharmaceutical and biotech industry another multi-billion dollar struggle has emerged: Read more…

Bayer acquires Merck’s consumer care business for an eye-catching price

Bayer AG Market Cap (09/05/2014): $115.17bn Merck & Co., Inc. Market Cap (09/05/2014): $161.23bn On May 6th, Bayer announced the acquisition of Merck’s consumer care business for a hefty $14.2bn, surpassing competing offers from Boehringer-Ingelheim and Reckitt Benckiser and, thus becoming the second largest company in over-the-counter (OTC) products worldwide. Read more…

Vodafone acquires Ono in a €7.2bn deal to strengthen its quad-play capabilities

Vodafone Group Plc. Market Cap (as of 21/03/14): £59.96bn Ono Market Cap (as of 21/03/14): N/A After having submitted several non-binding offers under €7bn, world’s second-largest wireless carrier Vodafone Group Plc. has confirmed the acquisition of Ono, a private-equity owned Spanish cable TV and internet provider, in a transaction worth Read more…

AMCOL deal update: Minerals Technologies tops Imerys’ bid

AMCOL International Corporation Market Cap (as of 14/03/2014): $1.49bn Minerals Technologies Inc. Market Cap (as of 14/03/2014): $1.98bn Imerys S.A. Market Cap (as of 14/03/2014): €4.76bn On March 10th, 2014 Minerals Technologies Inc., a global developer and maker of mineral-based products, announced it has signed a definitive merger agreement with Read more…